切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - haspin kinase - Hydroxylases - sodium channel - ErbB

11件产品中的 1-10

页面
每页
清除全部
  1. LDN 209929 dihydrochloride
    B7785 LDN 209929 dihydrochloride
    Target: haspin kinase
    Summary: Haspin激酶抑制剂
      <40.58 mg/mL
      <40.58 mg/mL
  2. L-Mimosine
    B4751 L-Mimosine
    Target: Hydroxylases
    Summary: 铁螯合剂和脯氨酰-4-羟化酶抑制剂
      insoluble in DMSO
      ≥1.98 mg/mL
  3. Ibutilide Fumarate
    B2278 Ibutilide Fumarate
    中文名: 富马酸伊布利特
    Target: Voltage-gated Potassium (KV) Channels|Voltage-gated Calcium Channels (CaV)|sodium channel
    Summary: III类抗心律失常药物
      ≥25.6 mg/mL
      ≥16.4 mg/mL
  4. Mubritinib (TAK 165)
    B1543 Mubritinib (TAK 165)
    中文名: 木利替尼
    Target: ErbB
    Summary: HER2/ErbB2有效抑制剂
      ≥76.9 mg/mL
      insoluble in H2O
  5. Lamotrigine
    B2249 Lamotrigine
     1 Citation
    中文名: 拉莫三嗪
    Target: 5-HT receptors|sodium channel
    Summary: 5-HT抑制剂,钠通道阻断剂
      ≥12.3 mg/mL
      insoluble in H2O
  6. AZD8931 (Sapitinib)
    A8375 AZD8931 (Sapitinib)
    中文名: 沙普替尼
    Target: EGFR|ErbB
    Summary: ErbB抑制剂
      ≥23.7 mg/mL
      insoluble in H2O
  7. Dacomitinib (PF299804, PF299)
    A8319 Dacomitinib (PF299804, PF299)
    中文名: 达克替尼
    Target: ErbB
    Summary: HER抑制剂
      ≥23.5 mg/mL
      insoluble in H2O
  8. Lapatinib
    A8218 Lapatinib
     2 Citation
    中文名: 拉帕替尼
    Target: ErbB
    Summary: EGFR/HER2抑制剂
      ≥29.05 mg/mL
      insoluble in H2O
  9. Dronedarone
    A3374 Dronedarone
    中文名: 决奈达隆
    Target: Cytochrome P450 (CYP450)|sodium channel|adrenergic receptor|potassium channel|calcium channel
    Summary: CYP3A4和2D6抑制剂
      ≥27.84 mg/mL
      insoluble in H2O
  10. Mildronate
    A4335 Mildronate
    中文名: 米屈肼
    Target: Hydroxylases|carnitine reabsorption
    Summary: GBB羟化酶抑制剂
      insoluble in DMSO
      ≥6.7 mg/mL

11件产品中的 1-10

页面
每页